Health Care & Life Sciences » Medical Equipment & Supplies | Rockwell Medical Inc.

Rockwell Medical Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
48,783.30
21,327.20
14,420.50
19,802.90
25,921.30
32,125.90
Depreciation, Depletion & Amortization
1,007.40
996.30
822.30
762.40
514.40
650.10
Other Funds
-
-
-
-
2,287.20
14,487.90
Funds from Operations
39,595.30
8,469.90
7,559.70
8,659.30
17,429.30
16,987.80
Changes in Working Capital
11,069.70
12,727.70
8,681.20
3,793.40
3,684.90
3,432.10
Net Operating Cash Flow
50,665.00
4,257.80
16,240.90
12,452.60
21,114.20
20,419.90
Capital Expenditures
654.20
684.60
815.00
355.30
1,682.90
Sale of Fixed Assets & Businesses
6.90
-
4.80
1.00
0.70
Purchase/Sale of Investments
12,002.20
8,124.00
20,331.30
1,290.20
16,185.10
Net Investing Cash Flow
12,649.50
8,808.60
21,141.50
1,644.40
14,502.90
Issuance/Reduction of Debt, Net
18,887.90
21,100.00
-
-
-
Net Financing Cash Flow
70,484.20
58,469.80
2,780.20
80.20
2,163.60
Net Change in Cash
7,169.70
53,919.00
34,602.30
14,017.60
8,773.70
Free Cash Flow
51,319.20
3,573.20
17,055.90
12,807.90
22,797.20
Change in Capital Stock
51,596.20
79,569.80
2,780.20
80.20
123.60
Exchange Rate Effect
-
-
-
0.70
1.30

About Rockwell Medical

View Profile
Address
30142 Wixom Road
Wixom Michigan 48393
United States
Employees -
Website http://www.rockwellmed.com
Updated 07/08/2019
Rockwell Medical, Inc. is a biopharmaceutical company, which operates through Hemodialysis Market segment that engages in the manufacture, sale, and distribution of hemodialysis products to hemodialysis clinics including pharmaceutical, dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. Its dialysis products include Triferic, Calcitriol Vitamin D Injection, Hemodialysis Concentrates, CitraPure, Dri-Sate, and ancillary products. The company was founded by Robert L.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.